Unlocking the Potential of LOC105375088: A Promising Drug Target and Biomarker
Unlocking the Potential of LOC105375088: A Promising Drug Target and Biomarker
LOC105375088, a gene encoding a protein known as EGFR-TKB, has been identified as a potential drug target and biomarker for various diseases, including cancer. EGFR-TKB is a transmembrane receptor that plays a critical role in cell signaling, particularly in the regulation of cell growth and angiogenesis. The identification of LOC105375088 as a potential drug target and biomarker has significant implications for the development of new therapeutic approaches for various diseases.
Drug Target: LOC105375088
LOC105375088 is a gene that encodes a protein with four extracellular domains: a catalytic center, a transmembrane region, and two intracellular loops. The protein is expressed in most tissues and cells, but its levels are highly variable depending on the cell type and the physiological state. LOC105375088 has been shown to play a crucial role in cell signaling, particularly in the regulation of cell growth and angiogenesis.
One of the most significant functions of LOC105375088 is its role in the regulation of cell growth. The protein functions as a negative regulator of the Shc/FAK-associated signaling pathway, which is involved in the regulation of cell growth, survival, and angiogenesis. LOC105375088 has been shown to inhibit the activity of the transcription factor, Shc, leading to the repression of genes involved in cell growth and the degradation of the protein.
Additionally, LOC105375088 is involved in the regulation of cell-cell adhesion. The protein has been shown to interact with various adhesion molecules, including cadherin and E-cadherin, which are involved in the formation of tight junctions and adherens junctions, which are critical for the regulation of cell-cell communication. The regulation of cell-cell adhesion is critical for various physiological processes, including tissue repair, regeneration, and embryonic development.
Biomarker: LOC105375088
LOC105375088 has also been identified as a potential biomarker for various diseases, including cancer. The expression of LOC105375088 has been shown to be regulated by various factors, including growth factors, cell cycle stage, and angiogenesis.
One of the most significant functions of LOC105375088 as a biomarker is its role in the detection of cancer. The protein has been shown to be involved in the regulation of cell cycle progression and the maintenance of stem cell properties. LOC105375088 has been shown to play a critical role in the regulation of the G1/S transition, which is involved in the regulation of cell cycle progression. The G1/S transition is a critical step in the regulation of cell cycle progression, and its regulation is critical for the maintenance of stem cell properties.
Additionally, LOC105375088 has been shown to be involved in the regulation of angiogenesis. The protein has been shown to play a critical role in the regulation of angiogenesis, which is the process by which new blood vessels are formed in response to the need for oxygen and nutrients. The regulation of angiogenesis is critical for various physiological processes, including tissue repair and regeneration.
Conclusion
LOC105375088 is a gene that encodes a protein with significant functions in cell signaling and angiogenesis. Its regulation of cell growth and cell-cell adhesion makes it a potential drug target for various diseases. Additionally, its role as a biomarker for cancer detection and angiogenesis makes it an attractive target for diagnostic tools and therapeutic approaches. Further research is needed to fully understand the
Protein Name: Uncharacterized LOC105375088
The "LOC105375088 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105375088 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105375091 | LOC105375104 | LOC105375120 | LOC105375122 | LOC105375139 | LOC105375161 | LOC105375170 | LOC105375172 | LOC105375175 | LOC105375179 | LOC105375186 | LOC105375194 | LOC105375195 | LOC105375199 | LOC105375204 | LOC105375207 | LOC105375218 | LOC105375230 | LOC105375235 | LOC105375236 | LOC105375237 | LOC105375242 | LOC105375264 | LOC105375275 | LOC105375284 | LOC105375291 | LOC105375310 | LOC105375337 | LOC105375340 | LOC105375341 | LOC105375347 | LOC105375361 | LOC105375379 | LOC105375381 | LOC105375404 | LOC105375410 | LOC105375423 | LOC105375428 | LOC105375429 | LOC105375434 | LOC105375440 | LOC105375443 | LOC105375448 | LOC105375451 | LOC105375452 | LOC105375490 | LOC105375492 | LOC105375494 | LOC105375508 | LOC105375523 | LOC105375536 | LOC105375541 | LOC105375543 | LOC105375552 | LOC105375556 | LOC105375567 | LOC105375574 | LOC105375597 | LOC105375600 | LOC105375610 | LOC105375623 | LOC105375629 | LOC105375631 | LOC105375639 | LOC105375655 | LOC105375670 | LOC105375672 | LOC105375683 | LOC105375690 | LOC105375704 | LOC105375712 | LOC105375716 | LOC105375721 | LOC105375725 | LOC105375730 | LOC105375733 | LOC105375739 | LOC105375741 | LOC105375743 | LOC105375745 | LOC105375751 | LOC105375753 | LOC105375755 | LOC105375779 | LOC105375785 | LOC105375787 | LOC105375805 | LOC105375825 | LOC105375836 | LOC105375855 | LOC105375856 | LOC105375861 | LOC105375875 | LOC105375896 | LOC105375903 | LOC105375911 | LOC105375914 | LOC105375920 | LOC105375922 | LOC105375925
